Rigetti Shares Skyrocket on Successful $100M Offering
Shares of Rigetti Computing surged after the company said it had successfully completed a sale of $100 million in common stock via an "at-the-market" equity offering. Shares gained about 70% to $2.96, ...
MarketWatch10m
Vuzix Shares Rise 17% After New Production Order
Vuzix shares were up 17% to $2 after the company said it received a six-figure revenue production order for customized waveguides to enable a lightweight heads-up display. Shares of the maker of smart ...
My children don’t care about me. I’m 61 and want to rewrite my will. Where do I start?
Dear Help Me Retire, I am 61 years old and looking to redo my will. I have a dilemma. I have two grown sons who do not have ...
Rocket Lab stock skyrockets on milestone launch weekend
Shares of Rocket Lab USA Inc. are up 11.5% in premarket trading after completing successful launches in two different hemispheres in less than 24 hours. At 10:55 p.m. Eastern time Sunday, Rocket Lab’s ...
Stocks open higher as investors cheer Bessent pick for Treasury
Stocks rose at the opening bell Monday, with investors attributing gains to relief over Donald Trump's selection of hedge-fund manager Scott Bessent to serve as Treasury secretary. "Risk on as markets ...
VIX kicks off Thanksgiving week lower to extend its November plunge
A gauge of U.S. stock-market anxiety was down Monday morning, kicking off Thanksgiving week with a sharp drop that extended its plunge so far this month. The Cboe Volatility Index, which trades under ...
California Resources Taps Banker Clio Crespy as CFO
California Resources on Monday named energy investment banker Clio Crespy as its next finance chief., effective Jan. 1. The Long Beach, Calif., oil and gas company said Chief Financial Officer Nelly ...
Wall Street analyst slaps the highest MicroStrategy stock-price target yet — here’s why.
Shares of MicroStrategy Inc. looked set to extend their bounce on Monday, after Benchmark analyst Mark Palmer raised his ...
BridgeBio Pharma Gets FDA Approval for Heart Disease Drug Attruby
The Palo Alto, California-based biopharmaceutical company said the Food and Drug Administration approved Attruby for adults with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...
MarketWatch49m
Brightcove Shares Jump to Take-Private Deal Price
Shares of Brightcove have surged close to the $4.45 acquisition price it has accepted from Italian technology company Bending Spoons. The stock was up 35% at $4.31 in premarket trading. Shares had ...
IPO for autonomous driving company Pony AI on deck for stock market debut
Pony AI, which makes technology for robot taxis and trucks, is set to price its U.S. initial public offering as early as Monday after the closing bell, according to market sources. China-based Pony AI ...